The appointment comes after Dr. Nabel stepped down from her role at Brigham Health, which includes Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and Brigham and Women’s Physicians Organization. She left the position at the end of February to pursue opportunities in biotech innovation.
Dr. Nabel sat on Moderna’s board from December 2015 to July 2020. She resigned in July 2020 to alleviate potential concerns about a conflict of interest between the outcome of Moderna’s COVID-19 vaccine trial and Brigham and Women’s Hospital. The hospital was one of the sites for the company’s phase 3 trial.
More articles on leadership and management:
Biden senior coronavirus adviser to leave White House by June
Biden to commemorate COVID-19 anniversary during first prime-time address
Former Kentucky hospital CEO Hank Wagner dead at 78; ‘put Jewish Hospital on the world map’
